Deutsche Märkte schließen in 3 Stunden 45 Minuten

Smith & Nephew plc (SN.L)

LSE - LSE Verzögerter Preis. Währung in GBp
Zur Watchlist hinzufügen
1.279,50-9,50 (-0,74%)
Ab 12:30PM BST. Markt geöffnet.

Smith & Nephew plc

Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100
http://www.smith-nephew.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter18.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Roland D. DiggelmannCEO & Director1,7MN/A1967
Ms. Anne-Francoise NesmesCFO & Exec. Director799,64kN/A1972
Mr. Andrew SwiftVP of Investor RelationsN/AN/AN/A
Ms. Catheryn O'RourkeChief Legal & Compliance OfficerN/AN/A1973
Mr. Joe MetzgerSr. VP of Marketing Services & CommunicationsN/AN/AN/A
Ms. Elga LohlerChief HR OfficerN/AN/A1968
Mr. Philip G. CowdyChief Bus. Devel. & Corp. Affairs OfficerN/AN/A1967
Mr. Bradley CannonPres of Sports Medicine & ENTN/AN/A1968
Dr. Vasant PadmanabhanPres of R&DN/AN/A1967
Steve KaneHead of HR for the US, Global Marketing and Global R&DN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2020 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Corporate Governance

Smith & Nephew plcs ISS Governance QualityScore, Stand 26. September 2021, lautet 4. Die grundlegenden Scores sind Audit: 3, Vorstand: 6, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.